Join ASGCT and save up to $350 on Annual Meeting registration!
Learn more about sessions and presentations at the 26th Annual Meeting
Thursday, May 18 2023 08:00 AM – 09:45 AM PT
This is a multidisciplinary session to present the latest non-viral gene delivery systems to target organs. Nanoparticles, exosomes, hydrodynamic therapy, and ultrasound (or electroporation) are promising non-viral means of delivering therapeutics that will be discussed in this session. Non-viral systems offer safe, versatile, and targeted therapeutic strategies.
08:00 AM – 09:45 AM - Petree Hall C
Jonathan Hoggatt, PHD. Moderna Therapeutics, Cambridge, MA
Daniel S. Scherman. CNRS-Inserm, Paris, France
08:01 AM – 08:25 AM - Petree Hall C
Kalina Paunovska, PhD; Biomedical Engineering. Nava Therapeutics, Cambridge, MA
08:25 AM – 08:50 AM - Petree Hall C
Lauren E.. Woodard, PhD. Vanderbilt University Medical Center, Nashville, TN, US Department of Veter...
08:50 AM – 09:15 AM - Petree Hall C
Angela K.. Pannier, PhD. University of Nebraska-Lincoln, LINCOLN, NE
09:15 AM – 09:40 AM - Petree Hall C
Mark J. Jaroszeski, BSCHE, MSCHE, PHD. University of South Florida, Tampa, FL
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico